Showing posts with label Rivaroxaban. Show all posts
Showing posts with label Rivaroxaban. Show all posts
Wednesday, June 20, 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

›
In continuation of my update on   rivaroxaban Research from the University of Warwick indicates that taking a tablet a day can help trea...
Thursday, November 30, 2017

FDA Approves New 10 mg Dosing for Xarelto (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)

›
In continuation of my update on  rivaroxaban Janssen Pharmaceuticals, Inc. announced  the U.S. Food and Drug Administration (FDA) ...
Wednesday, September 20, 2017

Two anticlotting medicines better at reducing bleeding risk than triple therapy

›
A major international study has found that the combination of two drugs - rivaroxaban and aspirin -- is superior to aspirin alone in preve...
Tuesday, January 26, 2016

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

›
In continuation of my update on  rivaroxaban Janssen Pharmaceuticals, Inc. (Janssen) and its development partner, Bayer Health...
Wednesday, October 2, 2013

Phase III EINSTEIN trial program: XARELTO reduces risk of DVT and PE

›
In continuation of my update on Rivaroxaban The EINSTEIN-PE study was an open-label, randomized, non-inferiority trial. The tria...
Tuesday, July 3, 2012

New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA

›
In continuation of my update on Rivaroxaban New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA :  The new ...
Thursday, February 9, 2012

New Anti-Clotting Drug May Cut Brain Bleeding Risk: Study

›
In continuation of my update on  rivaroxaban  ( Xarelto ) In a new study, researchers led by Dr. Graeme Hankey , a neurologist at the...
Tuesday, November 15, 2011

Janssen receives FDA approval for Xarelto to prevent stroke in people with AF

›
In continuation of my up date on rivaroxaban ..... Janssen receives FDA approval for Xarelto to prevent stroke in people with AF : The U...
Monday, September 12, 2011

›
In continuation of my updates on Rivaroxaban ... FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research &am...
Sunday, August 14, 2011

Study Pits New Blood Thinner Against Warfarin For Irregular Heartbeat

›
A new drug, Rivaroxaban, (see structure) that lowers stroke risk among people with an irregular heartbeat may give the old standby, warfar...
Sunday, July 10, 2011

FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis

›
We  know that,  Rivaroxaban  (structure below BAY 59-7939) is an  oral   anticoagulan t  invented and manufactured by  Bayer ; in a number...
1 comment:
Tuesday, December 1, 2009

Positive Results from Chronic Study of Rivaroxaban (anticoagulant drug)...

›
Rivaroxaban , is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto . If approved...